Bio-Gene Technology Signs research deal with University of Florida
- Bio-Gene Technology (BGT) signs a research agreement with the University of Florida, advancing its program to phase two
- The company has previously engaged with researchers at the University to test Qcide and Flavocide against resistant strains of flying insects
- Phase two will explore synergetic traits which may be evident in combination treatments of Qcide or Flavocide with other compounds
- The studies are set to commence early next year with reporting planned for early in the second quarter of 2022
- Bio-GeneTechnology shares are trading 2.56 per cent higher at 20 cents
